Blogs about: Beta 2 Adrenoceptor
Featured Blog
Seretide®/Advair treatment effective in COPD
Study results show that treatment with Seretide/Advair (salmeterol/fluticasone propionate ) slows the progression of Chronic Obstructive Pulmonary Disease (COPD) by lowering a patient’s rate of lung f… more →
GPCR News
Seretide®/Advair treatment effective in COPD
crimsoncanary wrote 1 year ago: Study results show that treatment with Seretide/Advair (salmeterol/fluticasone propionate ) slows th … more →
Seretide®/Advair treatment effective in COPD
crimsoncanary wrote 1 year ago: Study results show that treatment with Seretide/Advair (salmeterol/fluticasone propionate ) slows th … more →
SkyePharmas Third Flutiform Phase III Study meets endpoints
crimsoncanary wrote 1 year ago: SkyePharma have announced that its third Phase III trial of Flutiform in asthma patients has met its … more →
SkyePharmas Third Flutiform Phase III Study meets endpoints
crimsoncanary wrote 1 year ago: SkyePharma have announced that its third Phase III trial of Flutiform in asthma patients has met its … more →
AstraZeneca file sNDA for Symbicort for Asthma in children
crimsoncanary wrote 1 year ago: AstraZeneca have filed supplemental New Drug Application to the FDA for approval of Symbicort (budes … more →
Exacerbations in COPD reduced with Advair
crimsoncanary wrote 1 year ago: Advair Diskus 250/50 (fluticasone propionate and salmeterol) has been shown to reduce exacerbationsi … more →
AstraZeneca submit sNDA for Symbicort for COPD
crimsoncanary wrote 1 year ago: AstraZeneca have submitted a supplementary NDA for Symbicort (budesonide/formoterol fumarate dihydra … more →
FDA approves Advair 250/50 for COPD
crimsoncanary wrote 1 year ago: The FDA has approved Advair Diskus 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inha … more →
Sepracor settles patent dispute with Breath Ltd over Xopenex
crimsoncanary wrote 1 year ago: Sepracor have settled a patent dispute with Breath Ltd allowing Breath to launch generic versions of … more →
